Anna Niebling

Anna Niebling serves as the Global Executive Director for Medical Device & Diagnostic Solutions at Fortrea since June 2023, driving innovative commercial strategies and forming strategic partnerships. Previously, Anna held a similar role at Labcorp Drug Development from June 2021 to June 2023, overseeing global sales for medical devices and diagnostics services. Anna's extensive experience includes senior leadership positions at Covance, where responsibilities encompassed strategic accounts and cross-enterprise solutions, and roles in business development at Harlan Laboratories and ChemDiv. Anna founded AntiProt, providing immunological assays and reagents, and has also contributed to academia as an Associate Professor at Ludwig-Maximilians-Universität München. Anna's academic credentials include a PhD and Habilitation in Molecular Biology, Biochemistry, and Cell Biology from Ludwig-Maximilians-Universität München.